Menu
GWAS Study

Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.

Gudbjartsson DF, Holm H, Indridason OS et al.

20686651 PubMed ID
GWAS Study Type
46862 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GD
Gudbjartsson DF
HH
Holm H
IO
Indridason OS
TG
Thorleifsson G
EV
Edvardsson V
SP
Sulem P
DV
de Vegt F
DF
d'Ancona FC
DH
den Heijer M
WJ
Wetzels JF
FL
Franzson L
RT
Rafnar T
KK
Kristjansson K
BU
Bjornsdottir US
EG
Eyjolfsson GI
KL
Kiemeney LA
KA
Kong A
PR
Palsson R
TU
Thorsteinsdottir U
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Chronic kidney disease (CKD) is a worldwide public health problem that is associated with substantial morbidity and mortality. To search for sequence variants that associate with CKD, we conducted a genome-wide association study (GWAS) that included a total of 3,203 Icelandic cases and 38,782 controls. We observed an association between CKD and a variant with 80% population frequency, rs4293393-T, positioned next to the UMOD gene (GeneID: 7369) on chromosome 16p12 (OR = 1.25, P = 4.1x10(-10)). This gene encodes uromodulin (Tamm-Horsfall protein), the most abundant protein in mammalian urine. The variant also associates significantly with serum creatinine concentration (SCr) in Icelandic subjects (N = 24,635, P = 1.3 x 10(-23)) but not in a smaller set of healthy Dutch controls (N = 1,819, P = 0.39). Our findings validate the association between the UMOD variant and both CKD and SCr recently discovered in a large GWAS. In the Icelandic dataset, we demonstrate that the effect on SCr increases substantially with both age (P = 3.0 x 10(-17)) and number of comorbid diseases (P = 0.008). The association with CKD is also stronger in the older age groups. These results suggest that the UMOD variant may influence the adaptation of the kidney to age-related risk factors of kidney disease such as hypertension and diabetes. The variant also associates with serum urea (P = 1.0 x 10(-6)), uric acid (P = 0.0064), and suggestively with gout. In contrast to CKD, the UMOD variant confers protection against kidney stones when studied in 3,617 Icelandic and Dutch kidney stone cases and 43,201 controls (OR = 0.88, P = 5.7 x 10(-5)).

1,689 European ancestry cases, 37,076 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

46862
Total Participants
GWAS
Study Type
Yes
Replicated
1,972 European ancestry cases, 6,125 European ancestry controls
Replication Participants
European
Ancestry
Iceland, Netherlands
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.